AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gervais, D. A.
Right arrow Articles by Mueller, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gervais, D. A.
Right arrow Articles by Mueller, P. R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Percutaneous Radiofrequency Ablation of Ovarian Cancer Metastasis to the Liver: Indications, Outcomes, and Role in Patient Management

Debra A. Gervais1, Ronald S. Arellano1 and Peter R. Mueller1

1 All authors: Department of Radiology, Massachusetts General Hospital, 55 Fruit St., White 270, Boston, MA 02114.


Figure 1
View larger version (128K):

[in a new window]
  		Fig. 1A —48-year-old woman. Enhanced CT scan of abdomen shows focal hepatic metastatic lesion (arrow) from ovarian cancer.

 

Figure 2
View larger version (130K):

[in a new window]
  		Fig. 1B —48-year-old woman. Unenhanced CT scan at radiofrequency ablation shows straight needle electrode with tip (arrow) in tumor.

 

Figure 3
View larger version (140K):

[in a new window]
  		Fig. 1C —48-year-old woman. Enhanced CT scan 1 month after radiofrequency ablation shows large zone of ablation (arrow) encompassing tumor and margin of normal liver.

 

Figure 4
View larger version (127K):

[in a new window]
  		Fig. 1D —48-year-old woman. Enhanced CT scan 1.5 years after radiofrequency ablation shows involution of zone of ablation (arrow).

 

Figure 5
View larger version (102K):

[in a new window]
  		Fig. 2A —80-year-old woman with 5.3-cm hepatic metastatic lesion from ovarian cancer. Unenhanced CT scan at radiofrequency ablation shows large liver tumor (arrow) from ovarian cancer.

 

Figure 6
View larger version (115K):

[in a new window]
  		Fig. 2B —80-year-old woman with 5.3-cm hepatic metastatic lesion from ovarian cancer. Unenhanced CT scan at radiofrequency ablation shows multitined electrode (arrow) deployed into tumor.

 

Figure 7
View larger version (124K):

[in a new window]
  		Fig. 2C —80-year-old woman with 5.3-cm hepatic metastatic lesion from ovarian cancer. Enhanced CT scan 9 months after radiofrequency ablation shows involution of zone of ablation (arrow).

 

Figure 8
View larger version (120K):

[in a new window]
  		Fig. 2D —80-year-old woman with 5.3-cm hepatic metastatic lesion from ovarian cancer. Enhanced CT scan 9 months after radiofrequency ablation along caudal aspect of zone of ablation (arrow) shows that this area is slightly denser, raising possibility of enhancement versus volume-averaging artifact.

 

Figure 9
View larger version (82K):

[in a new window]
  		Fig. 2E —80-year-old woman with 5.3-cm hepatic metastatic lesion from ovarian cancer. FDG PET scan shows area in question (arrow) is FDG avid and represents recurrent tumor.

 

Figure 10
View larger version (87K):

[in a new window]
  		Fig. 2F —80-year-old woman with 5.3-cm hepatic metastatic lesion from ovarian cancer. FDG PET scan after second ablation session shows absence of uptake in zone of ablation (arrow), confirming complete treatment.

 

Figure 11
View larger version (131K):

[in a new window]
  		Fig. 2G —80-year-old woman with 5.3-cm hepatic metastatic lesion from ovarian cancer. Enhanced CT scan 1 year after second ablation shows stable zone of ablation (arrow).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.